Instrument Inactif

Autres langues Venn Life Sciences Holdings Cinnober Boat

Actions

VENN

GB00B9275X97

Recherche biotechnologique et médicale

Autres langues

15/09	EARNINGS: hVIVO CFO to retire; Personal Group sales and profit climb
15/09	HVIVO CFO to Step Down; Interim CFO Named
15/09	Earnings Flash (HVO.L) hVIVO plc Reports H1 Revenue GBP16.3M
15/09	HVIVO plc Announces CFO Changes
15/09	HVIVO plc Provides Earnings Guidance for the Second Half of Full Year Ending 31 December 2026; Provides Group Earnings Guidance for the Full Year Ending 31 December 2026
27/08	HVIVO plc acquired Crs Clinical Research Services Management GmbH for ?6.025 million.
27/08	HVIVO buys CRS Berlin as expands into dermatology and women's health
27/08	HVIVO Acquires German Research Institute CRS Clinical Research
27/08	HVIVO acquires CRS Berlin, expanding expertise into dermatology and women's health markets
23/07	LPA in Boeing Distribution deal; Fonix profit grows
23/07	HVIVO plc Provides Earnings Guidance for the First Half Ended 30 June 2026 and Full Year 2026
23/07	HVIVO : H1 2026 Trading Update
24/06	HVIVO PLC Announces Termination of Appointment of Professor Brendan Mary Buckley from Director Role, Effective May 13, 2026
01/06	Caledonia Investments sells Stonehage Fleming stake
01/06	HVIVO plc Signs Consultancy Contract With Decoy Therapeutics
01/06	Decoy Therapeutics Inc. and hVIVO plc Partner to Advance Lead D-Mav Candidate into the Clinic
07/05	HVIVO Secures GBP6 Million Deal to Run Influenza Human Challenge Trial for Monoclonal Antibody
07/05	EARNINGS AND TRADING: MHA expects profit beat; hVIVO wins work
07/05	WINNERS & LOSERS: S4 Capital hit by "client caution"; NAHL in profit
07/05	HVIVO announces 6 mln Stg influenza hct contract
07/05	HVIVO PLC Signs GBP 6 Million Influenza HCT Contract With Clinical-Stage Biopharmaceutical Company
22/04	EARNINGS & TRADING: Rift Helium trading on AIM, raises GBP8.1 million
22/04	HVIVO to Run Late-stage Human Challenge Trial for ILiAD's Whooping Cough Vaccine Candidate
22/04	HVIVO to conduct phase III human challenge whooping cough vaccine trial for ILiAD Biotechnologies
22/04	HVIVO plc Signs Contract with ILiAD Biotechnologies, Inc